Counsel for Torrent in Daliresp Hatch-Waxman Litigation
September 29, 2017
AstraZeneca and Takeda v. Torrent Pharmaceuticals Ltd.
Robins Kaplan LLP served as counsel for Torrent in Hatch-Waxman patent litigation in the District of New Jersey involving a number of patents related to COPD medication Daliresp (roflumilast). The parties entered into a consent judgment on September 29, 2017.
If you are interested in having us represent you, you should call us so we can determine whether the matter is one for which we are willing or able to accept professional responsibility. We will not make this determination by e-mail communication. The telephone numbers and addresses for our offices are listed on this page. We reserve the right to decline any representation. We may be required to decline representation if it would create a conflict of interest with our other clients.
By accepting these terms, you are confirming that you have read and understood this important notice.